Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2001
11/15/2001WO2001085770A2 Sentinel virus ii
11/15/2001WO2001085769A2 Structure of g-protein (rgs4) and methods of identifying agonists and antagonists using same
11/15/2001WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001WO2001085759A1 Separation of avian antibodies
11/15/2001WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001WO2001085366A1 Eating quality grade
11/15/2001WO2001085341A1 Microfluidic devices
11/15/2001WO2001085334A2 Chemical structure identification
11/15/2001WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001WO2001085157A1 Compositions and methods for treatment of proliferative disorders
11/15/2001WO2001085142A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/15/2001WO2001085096A2 Mast cell regulation
11/15/2001WO2001084951A1 Insecticide resistance assay
11/15/2001WO2001084940A2 Method and system for controlling mixing processes
11/15/2001WO2001076627A8 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
11/15/2001WO2001049879A3 Methods for comparing gene expression levels or patterns in normal or tumor cells
11/15/2001WO2001049729A8 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
11/15/2001WO2001042794A3 Method for identifying inhibitors of cytokinesis
11/15/2001WO2001042487A3 Device for extraction of nucleic acids
11/15/2001WO2001033214A3 Test element analysis system with an infrared detector
11/15/2001WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001WO2001031989A3 High throughput screening (hts) assays for protein variants with reduced antibody binding capacity
11/15/2001WO2001020023A3 Method for the detection of oxidized forms of soluble guanylate cyclase
11/15/2001WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001WO2001016150A3 Nucleoside analogues
11/15/2001WO2001013111A3 Allele detection of pgm1, gc, and aat
11/15/2001WO2001011361A3 Kit and method to assess the malignancy of neoplasias
11/15/2001WO2001009616A3 Method for determining physiological effects of hemoglobin
11/15/2001WO2001007160A3 Two-part microplate comprising thin-well insert and related fabrication method
11/15/2001WO2001007088A3 Methods for treating therapy-resistant tumors
11/15/2001WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001WO2000067737A3 USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000061636A3 Aberrantly glycosylated antibodies as marker for cancer
11/15/2001WO2000055323A9 Differential expression of organellar gene products
11/15/2001WO2000054730A3 Compositions preparations and uses of human papillomavirus l1 protein
11/15/2001WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001WO2000050872A9 A system for cell-based screening
11/15/2001WO2000043772A9 Micro-machined thin film hydrogen gas sensor, and method of making and using the same
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001US20010041964 Pharmacokinetic-based drug design tool and method
11/15/2001US20010041743 Prostaglandins
11/15/2001US20010041732 Use
11/15/2001US20010041670 Activity of thrombospondin (TSP-1), an antiangiogenic protein, can be modulated by stimulating or inhibiting the activity of Histidine-Rich Glycoprotein (HRGP) or a protein that includes thrombospondin binding motif of HRGP
11/15/2001US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001US20010041369 Method for producing micro-carrier and test method by using said micro-carrier
11/15/2001US20010041368 Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
11/15/2001US20010041367 Measures change in optical density indicating composition of liquid sample without requiring accurate control of amount and position of liquid sample dripped on dry chemical analysis element; accuracy, for blood, urine
11/15/2001US20010041366 Trace level detection of analytes using artificial olfactometry
11/15/2001US20010041365 Determining concentration of ethyl oleate and ethyl palmitate in sample from subject, determining ratio of concentration of ethyl palmitate to ethyl oleate in sample, where ratio less than 0.9 is indicative of chronic alcoholic
11/15/2001US20010041357 Polymerase chain reaction
11/15/2001US20010041351 Transition metal oxide
11/15/2001US20010041349 Genetic engineering; computers
11/15/2001US20010041347 Using computers
11/15/2001US20010041346 Complex of cyclic guanosine monophosphate protein kinase and myosin phosphatase
11/15/2001US20010041344 On solid support
11/15/2001US20010041343 Antibody coated microspheres
11/15/2001US20010041342 Using apoptosis inhibiting protein
11/15/2001US20010041340 Genetic engineering
11/15/2001US20010041339 Bundling fibers; gluing to backing
11/15/2001US20010041338 Method for producing micro-carrier and test method by using said micro-carrier
11/15/2001US20010041334 Genetic engineering
11/15/2001US20010041333 High throughput screening for a bioactivity or biomolecule
11/15/2001US20010041331 Methods of utilizing the TT virus
11/15/2001US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001US20010041177 Biomarker molecule CD163, antibody complex
11/15/2001US20010040679 Surface plasmon resonance sensor apparatus using surface emitting laser
11/15/2001US20010040509 Apparatus and method for wireless gas monitoring
11/15/2001US20010040232 Emit light in visible energy range
11/15/2001US20010040130 Detection of pyrogen and other impurities in water
11/15/2001US20010039824 Handheld sensing apparatus
11/15/2001DE10123663A1 Device for measuring deformation of mortar in two directions under different temperature conditions has sensors for simultaneous measurement of vertical and horizontal mortar movement
11/15/2001DE10029537C1 Mineral loose material sampling method uses separation grid, turbine and cyclone for separation of successive material quantities to provide X-ray fluorescence sample
11/15/2001DE10023423A1 Direct detection of substances such as biopolymer analytes in bodily fluid, comprises the formation of a marked analyte-receptor complex for identification during flow through microchannel
11/15/2001DE10022549A1 Detector, for determining liquid taken from body of water, comprises support and active ingredient which changes action of predetermined materials in liquid or liquid stream to be investigated
11/15/2001DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway
11/15/2001DE10021737A1 Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein-und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird Method and apparatus for qualitative and / or quantitative determination of a protein and / or peptide pattern in a liquid sample which is derived from a human or animal body
11/15/2001DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001DE10021390A1 Protection solution for fixing samples for paraffin embedding, comprising amino acids and sugars, eliminates the need for aldehyde crosslinkers and retains protein structures
11/15/2001DE10018954A1 Verfahren zur Beschichtung von Kunststoff-Festphasen Process for coating plastic solid phase
11/15/2001CA2804977A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001CA2768046A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001CA2535867A1 Mixed cell diagnostic systems
11/15/2001CA2412302A1 Chemical sensor device
11/15/2001CA2409717A1 Assay for cell cycle modulators
11/15/2001CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001CA2409512A1 Improvements to the fluorescent polymer-qtl approach to biosensing
11/15/2001CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001CA2409150A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001CA2408930A1 Structure of g-protein (rgs4) and methods of identifying agonists and antagonists using same
11/15/2001CA2408921A1 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001CA2408850A1 Platelet function assay and reagent therefor
11/15/2001CA2408840A1 Myc targets
11/15/2001CA2408828A1 Novel serine-threonine kinase-4
11/15/2001CA2408812A1 Methods of identifying the activity of gene products